NASDAQ Equity Snapshot
DRUG Weekly Equity Report
Bright Minds Biosciences Inc
What the company does
Bright Minds Biosciences Inc. (DRUG) is an innovative clinical-stage biotechnology company focused on developing groundbreaking therapies for central nervous system disorders, emphasizing mental health and pain management. Utilizing its proprietary drug development platform, the firm is advancing a diverse pipeline that highlights both effectiveness and safety, in line with the rising acceptance of psychedelic treatments. With a highly experienced management team and a robust intellectual property portfolio, Bright Minds is well-positioned to leverage the increasing demand for novel mental health solutions, representing a compelling opportunity for institutional investors seeking significant growth in the evolving pharmaceutical …
What the weekly tape is saying
DRUG closed the latest completed week at 60.95 USD. The 4-week return is -21.3% and the 12-week return is -14.9%. Trend Signal is inactive, Market Dynamics is -0.17. Setup signature: Risk-first tape with a 26/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 79.39 USD
- Vs Trend Line
- -23.2%
- Fair Value
- 30.45 USD
- Vs Fair Value
- 100.2%
- 52W High
- 123.8 USD
- 52W Low
- 23.18 USD
- Drawdown
- -50.7%
- Range Position
- 37.6%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 39
- 52W Active Breadth
- 75.0%
- Sector Scope
- US Healthcare
- Sector Rank
- 964 of 1038
- Sector Percentile
- 7.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.17
- 4W MD Change
- -237.1%
- Relative Strength
- -19.09
- 4W RS Change
- -317.9%
- Expectation
- Negative
- Probability
- 41.72%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.7M
- 13W Average
- 1.3M
- 52W Average
- 772.0K
- Vs 13W
- 2.1x
- Vs 52W
- 3.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 9.4%
- 52W Volatility
- 10.3%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 9.7% / -5.6%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 878.1M
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 60.95 USD | -11.7% | 79.39 USD | 30.45 USD | -0.17 | -19.09 | 2.7M | Off |
| 5 Jun 2026 | 69.00 USD | -21.7% | 79.29 USD | 30.08 USD | -0.02 | -5.73 | 3.1M | Off |
| 29 May 2026 | 88.07 USD | 5.5% | 78.95 USD | 29.66 USD | 0.13 | 15.88 | 936.4K | On |
| 22 May 2026 | 83.50 USD | 7.8% | 77.83 USD | 29.11 USD | 0.16 | 14.52 | 1.6M | On |
| 15 May 2026 | 77.47 USD | -9.4% | 77.09 USD | 28.59 USD | 0.12 | 8.76 | 1.1M | On |
| 8 May 2026 | 85.50 USD | -1.7% | 76.61 USD | 28.11 USD | 0.13 | 20.70 | 840.4K | On |
| 1 May 2026 | 86.96 USD | -2.5% | 75.87 USD | 27.58 USD | -0.00 | 30.86 | 1.2M | On |
| 24 Apr 2026 | 89.16 USD | -0.8% | 74.75 USD | 27.04 USD | -0.33 | 37.94 | 783.7K | On |
| 17 Apr 2026 | 89.90 USD | 7.6% | 73.53 USD | 26.49 USD | -0.64 | 44.15 | 658.0K | On |
| 10 Apr 2026 | 83.55 USD | 16.9% | 72.31 USD | 25.94 USD | -0.89 | 44.08 | 988.1K | On |
| 2 Apr 2026 | 71.46 USD | 1.9% | 71.15 USD | 25.41 USD | -1.06 | 30.66 | 891.5K | On |
| 27 Mar 2026 | 70.10 USD | -2.1% | 70.18 USD | 24.97 USD | -1.06 | 34.55 | 708.9K | On |
| 20 Mar 2026 | 71.62 USD | -0.5% | 69.14 USD | 24.53 USD | -0.89 | 34.33 | 801.6K | On |
| 13 Mar 2026 | 72.00 USD | -6.3% | 68.22 USD | 24.09 USD | -0.67 | 33.78 | 852.4K | On |